mortality/aging
• 5% lethality, surviving mutants had an intact floxed allele
|
hematopoietic system
• moderate anemia at 4 and 2 weeks after the initiation of poly(I)-poly(C) (pIpC) treatment to induce cre expression
|
• moderate thrombocytopenia at 2 and 4 weeks after the initiation of pIpC treatment
|